Clicky

clear pixel

Bringing New Perspectives

To Soft Tissue Repair

clear pixel
clear pixel
clear pixel
clear pixel

Research & Development Milestones

clear pixel
clear pixel

Biocompatibility and Histopathology

XI-S+™ has undergone extensive ISO 10993 pre-clinical testing in support of US FDA 510 (k) clearance. XI-S+™ has demonstrated:1

  • Extremely low glutaraldehyde and DNA residuals, and
  • Strong, durable, and biocompatible.
  1. Colorado Therapeutics LLC. Data on file.
clear pixel
clear pixel

XI-S+™ In Hernia Repair

XI-S+™ has been studied in ventral and inguinal overlay procedures in a clinical program conducted outside of the US. The novel cross-linked XI-S+™ porcine pericardial biomaterial has been implanted with over 1 year of follow-up and was demonstrated to be well-suited for repairing hernia defects1.

  1. Colorado Therapeutics LLC. Data on file.
clear pixel
+ Upcoming Data Presentations